Immediate Impact
2 from Science/Nature 50 standout
Citing Papers
Polymeric Nanoparticles for Drug Delivery
2024 Standout
Understanding and targeting resistance mechanisms in cancer
2023 Standout
Works of Larry Schlabach being referenced
Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: a multicenter phase II study.
2001
A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non–small-cell lung cancer (a Vanderbilt cancer center affiliate network study)
2000
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Larry Schlabach | 147 | 181 | 102 | 10 | 295 | |
| Roy Herbst | 117 | 139 | 89 | 12 | 324 | |
| S. Korfee | 247 | 200 | 80 | 14 | 315 | |
| Denise Stys‐Norman | 200 | 179 | 85 | 9 | 329 | |
| Priyanka Gopal | 123 | 90 | 114 | 14 | 300 | |
| Melinda E. Stack | 110 | 150 | 77 | 13 | 310 | |
| Anne Moxhon | 180 | 131 | 102 | 8 | 318 | |
| Shahin Shajahan | 130 | 63 | 103 | 9 | 311 | |
| T. Waldron | 175 | 78 | 95 | 10 | 314 | |
| Sandra Biggar | 127 | 63 | 112 | 8 | 289 | |
| Feiying Gu | 92 | 102 | 126 | 11 | 297 |
All Works
Loading papers...